Comparison of VTD (velcade-thalidomide-dexamethasone) and a conventional chemotherapy induction regimen: effect on stem cell mobilization and engraftment of ASCT (autologous stem cell transplantation) for newly diagnosed multiple myeloma

被引：0
|
作者：
Requena, M. J. [1 ]
Yebra, E. [1 ]
Berberana, M. [1 ]
Payamps, C. [1 ]
Diaz Goizueta, M. [1 ]
Riaza, R. [1 ]
Penalver, M. A. [1 ]
Rodriguez, R. [1 ]
Sanchez Godoy, P. [1 ]
机构：
[1] Hosp Severo Ochoa, Madrid, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S212 / S213
页数：2
相关论文
共 50 条
  • [41] Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Moreau, Philippe
    Avet-Loiseau, Herve
    Facon, Thierry
    Attal, Michel
    Tiab, Mourad
    Hulin, Cyrille
    Doyen, Chantal
    Garderet, Laurent
    Randriamalala, Edouard
    Araujo, Carla
    Lepeu, Gerard
    Marit, Gerald
    Caillot, Denis
    Escoffre, Martine
    Lioure, Bruno
    Benboubker, Lotfi
    Pegourie, Brigitte
    Kolb, Brigitte
    Stoppa, Anne Marie
    Fuzibet, Jean-Gabriel
    Decaux, Olivier
    Dib, Mamoun
    Berthou, Christian
    Chaleteix, Carine
    Sebban, Catherine
    Traulle, Catherine
    Fontan, Jean
    Wetterwald, Marc
    Lenain, Pascal
    Mathiot, Claire
    Harousseau, Jean-Luc
    BLOOD, 2011, 118 (22) : 5752 - 5758
  • [42] Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
    Morgan, Gareth J.
    Davies, Faith E.
    Gregory, Walter M.
    Bell, Sue E.
    Szubert, Alexander J.
    Coy, Nuria Navarro
    Cook, Gordon
    Feyler, Sylvia
    Johnson, Peter R. E.
    Rudin, Claudius
    Drayson, Mark T.
    Owen, Roger G.
    Ross, Fiona M.
    Russell, Nigel H.
    Jackson, Graham H.
    Child, J. Anthony
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 442 - 450
  • [43] Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients
    Shuichiro Takashima
    Toshihiro Miyamoto
    Masanori Kadowaki
    Yoshikiyo Ito
    Takatoshi Aoki
    Ken Takase
    Takahiro Shima
    Goichi Yoshimoto
    Koji Kato
    Tsuyoshi Muta
    Motoaki Shiratsuchi
    Katsuto Takenaka
    Hiromi Iwasaki
    Takanori Teshima
    Tomohiko Kamimura
    Koichi Akashi
    International Journal of Hematology, 2014, 100 : 159 - 164
  • [44] Rates of Upfront Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (NDMM): A report from the MRDR
    Bergin, Krystal
    Moore, Elizabeth
    McQuilten, Zoe
    Augustson, Bradley
    Blacklock, Hilary
    D'Rozario, James
    Dickinson, Michael
    Estell, Jane
    Ho, P. Joy
    He, Simon
    Hocking, Jay
    Horvath, Noemi
    King, Tracy
    Leung, Teresa
    McNeil, John
    Merriman, Luke
    Mollee, Peter
    Prince, H. Miles
    Quach, Hang
    Ramanathan, Sundra
    Reid, Christopher
    Rosengarten, Brian
    Srivastava, Gaurav
    Sobieraj-Teague, Magdalena
    Spearing, Ruth
    Walker, Patricia
    Wright, Tricia
    Wood, Erica
    Spencer, Andrew
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E30 - E31
  • [45] Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Sauer, Sandra
    Kriegsmann, Katharina
    Nientiedt, Cathleen
    Schmitt, Anita
    Mueller-Tidow, Carsten
    Raab, Marc-Steffen
    Kauer, Joseph
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2023, 50 (05) : 371 - 380
  • [46] Thalidomide and dexamethasone in newly diagnosed multiple myeloma: Long-term results in patients not undergoing upfront autologous stem cell transplantation.
    Rajkumar, SV
    Dingli, D
    Nowakowski, G
    Gertz, M
    Lacy, MQ
    Dispenzieri, A
    Hayman, S
    Zeldenrust, SR
    Fonseca, R
    Lust, JA
    Greipp, PR
    Kyle, RA
    Witzig, TE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 593S - 593S
  • [47] Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patients
    Takashima, Shuichiro
    Miyamoto, Toshihiro
    Kadowaki, Masanori
    Ito, Yoshikiyo
    Aoki, Takatoshi
    Takase, Ken
    Shima, Takahiro
    Yoshimoto, Goichi
    Kato, Koji
    Muta, Tsuyoshi
    Shiratsuchi, Motoaki
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Teshima, Takanori
    Kamimura, Tomohiko
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (02) : 159 - 164
  • [48] Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial
    Dingli, David
    Rajkumar, S. Vincent
    Nowakowski, Grzegorz S.
    Gertz, Morie A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Hayman, Suzanne
    Fonseca, Rafael
    Lust, John A.
    Kyle, Robert A.
    Greipp, Philip R.
    Witzig, Thomas E.
    HAEMATOLOGICA, 2005, 90 (12) : 1650 - 1654
  • [49] Mobilization of autologous peripheral blood haematopoietic stem cells for newly-diagnosed multiple myeloma treated with cyclophosphamide, thalidomide and dexamethasone regimen, experience in Macedonia
    Georgievski, B.
    Cevreska, L.
    Stojanoski, Z.
    Stavrik, S. Genadieva
    Chadievski, L.
    Grubovic, R.
    Useini, S.
    Veljanovska, A. Pivkova
    BONE MARROW TRANSPLANTATION, 2013, 48 : S545 - S545
  • [50] A Phase II Study of Sequential Velcade/Thalidomide/Dexamethasone (VTD) as Maintenance Therapy Post Single Autologous Peripheral Stem Cell (PSCT) in Patients with Multiple Myeloma
    Sahebi, Firoozeh
    Krishnan, Amrita
    Somlo, George
    Popplewell, Leslie
    Parker, P.
    Cai, Ji-Lian
    Farol, Len
    Spielberger, Ricardo
    Kogut, Neil Martin
    Karanes, Chatchada
    Ruel, Christopher
    Frankel, Paul
    Arceo, Fermin
    Duarte, Lupe
    O'Donnell, Margaret
    Forman, Stephen J.
    BLOOD, 2009, 114 (22) : 1321 - 1322
12345